Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 04 tags : Therapy save search
Athenex to Acquire Kuur Therapeutics to Expand Cell Therapy Development with Off-the-Shelf Engineered CAR-NKT Platform
Published: 2021-05-04 (Crawled : 22:00) - globenewswire.com
ATNX | $0.2031 -7.78% 1.9M
|
Health Technology
|
| O: 36.66%
H: 13.41%
C: -10.26%
therapy
ImmunityBio Announces 78 Percent Complete Response Following Chemotherapy-Free Combination of IL-15 Superagonist Anktiva with Rituxan in Relapsed Non-Hodgkin Lymphoma Patients
Published: 2021-05-04 (Crawled : 13:15) - nantkwest.com
IBRX | $5.0 1.21% 17M
|
Manufacturing
|
| O: -1.39%
H: 1.18%
C: -7.06%
therapy
Taysha Gene Therapies to Release First Quarter 2021 Financial Results and Host Conference Call and Webcast on May 11
Published: 2021-05-04 (Crawled : 12:15) - biospace.com/
TSHA | $2.555 3.86% 440K
|
Health Technology
|
| O: -0.76%
H: 2.78%
C: -3.04%
financial results gene therapies results conference gene therapy therapy
AGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting
Published: 2021-05-04 (Crawled : 12:15) - globenewswire.com
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: -2.91%
H: 0.75%
C: -3.0%
gene therapy therapy aav9 gene therapies
LogicBio Announces Presentations at Upcoming American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
Published: 2021-05-04 (Crawled : 12:00) - prnewswire.com
LOGC | $2.07 -0.48%
|
Health Technology
|
| O: -1.1%
H: 1.66%
C: -6.48%
presentation therapy
Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to EnrollmentNext Cohort to Enroll Patients on Background Therapy of Disopyramide
Published: 2021-05-04 (Crawled : 12:00) - biospace.com/
CYTK | $68.095 2.72% 100K
|
Health Technology
|
| O: -1.2%
H: 1.56%
C: -5.31%
therapy enroll
Lilly accelerating baricitinib's availability in India following receipt of permission for restricted emergency use as a COVID-19 therapy via donations and licensing agreements
Published: 2021-05-04 (Crawled : 11:00) - prnewswire.com
LLY | News | $739.11 1.06% 320K
|
Health Technology
|
| O: 0.87%
H: 1.36%
C: 0.36%
covid baricitinib therapy india merge license
Gainers vs Losers
| 89% | 11% |
Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M
|
AGBA | $2.355 88.4% 34M
|
Finance
EDBL | News | $6.75 79.52% 1.5M
|
CZOO | $8.77 75.75% 11M
|
VNRX | $0.84 40.0% 2.6M
|
Health Technology
OPRT | News | $3.01 33.78% 6.8M
|
Finance
MLEC | $1.81 29.29% 2M
|
n/a
CMAX | $4.12 28.35% 65K
|
Manufacturing
MTC | $2.0 28.21% 1.7M
|
Technology Services
PEGY | $0.0586 27.95% 130M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.